Blinn Mark A
Director at TXN; Director at GL; Director at EMR, and 1 more
- Sold, on record
- $55.9M
- Dollars the filings state
- Form 4 sales
- 38
- Latest Apr 24, 2026
- Form 144 notices
- 10
- Proposed sales
- Companies
- 4
- Filed as an executive or holder
Companies
Sales by reason
0
Routine
10
Plan not stated
6
No plan
22
Unusual
Form 4 sales per year, every sale on record.
Sales by company
Shares sold, every Form 4 sale on record.
Timeline
- Apr 24, 2026Unusual
Sold 99.7% of their holdings
$4.2M15,000 shares at $277.51
- Apr 24, 2026Notice
Filed a notice to sell 15,000 shares
$4.1M15,000 shares
- Feb 6, 2026Unusual
Sold 34.2% of their holdings
$259k1,750 shares at $147.91
- Feb 6, 2026Notice
Filed a notice to sell 1,750 shares
$259k1,750 shares
- Feb 5, 2026Unusual
Sold 27.6% of their holdings
$439k2,876 shares at $152.62
- Feb 5, 2026Unusual
Sold 21.2% of their holdings
$697k3,144 shares at $221.58
- Feb 5, 2026Notice
Filed a notice to sell 2,876 shares
$439k2,876 shares
- Feb 5, 2026Notice
Filed a notice to sell 3,144 shares
$697k3,144 shares
- Jul 21, 2025No plan
Sold under 0.1% of their holdings
$720 shares at $216.75
- Feb 19, 2025Unusual
Sold 34.6% of their holdings
$1.2M6,186 shares at $189.89
10 of 48
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| May 21, 2026 | May 26, 2026 | Q | Director | Awarded | 1,278 | 5,645 | SEC | ||
| Apr 24, 2026 | Apr 27, 2026 | TXN | Director | Sold | 15,000 | $277.51 | $4.2M | 46 | SEC |
| Feb 6, 2026 | Feb 10, 2026 | GL | Director | Sold | 1,750 | $147.91 | $259k | 3,372 | SEC |
| Feb 5, 2026 | Feb 9, 2026 | EMR | Director | Sold | 2,876 | $152.62 | $439k | 7,555 | SEC |
| Feb 5, 2026 | Feb 6, 2026 | TXN | Director | Sold | 3,144 | $221.58 | $697k | 11,670 | SEC |
| Feb 5, 2026 | Feb 6, 2026 | TXN | Director | Exercised or settledNQ Stock Option (Right to Buy) | 2,572 | 1,914 | SEC | ||
| Feb 5, 2026 | Feb 6, 2026 | TXN | Director | Exercised options | 2,572 | $175.48 | $451k | 14,814 | SEC |
| Feb 3, 2026 | Feb 5, 2026 | EMR | Director | Awarded | 1,251 | 10,431 | SEC | ||
| Jan 29, 2026 | Feb 2, 2026 | TXN | Director | AwardedNQ Stock Option (Right to Buy) | 1,860 | 1,860 | SEC | ||
| Jan 29, 2026 | Feb 2, 2026 | TXN | Director | Awarded | 525 | 12,242 | SEC | ||
| Jan 2, 2026 | Jan 5, 2026 | GL | Director | Awarded | 1,373 | 6,495 | SEC | ||
| Dec 3, 2025 | Dec 5, 2025 | Q | Director | Awarded | 4,364 | 4,364 | SEC | ||
| Jul 25, 2025 | Feb 10, 2026 | GL | Director | Gift | 3,208 | 5,122 | SEC | ||
| Jul 21, 2025 | Aug 27, 2025 | TXN | Director | Sold | 0 | $216.75 | $72 | 3,046 | SEC |
| Feb 19, 2025 | Feb 20, 2025 | TXN | Director | Sold | 6,186 | $189.89 | $1.2M | 11,717 | SEC |
| Feb 19, 2025 | Feb 20, 2025 | TXN | Director | Exercised or settledNQ Stock Option (Right to Buy) | 6,186 | 2,300 | SEC | ||
| Feb 19, 2025 | Feb 20, 2025 | TXN | Director | Exercised options | 6,186 | $171.55 | $1.1M | 17,903 | SEC |
| Feb 12, 2025 | Feb 14, 2025 | EMR | Director | Sold | 20 | $125.24 | $3k | 9,180 | SEC |
| Feb 10, 2025 | Feb 12, 2025 | EMR | Director | Sold | 1,867 | $125.71 | $235k | 9,200 | SEC |
| Feb 4, 2025 | Feb 5, 2025 | TXN | Director | Sold | 590 | $180.71 | $107k | 11,717 | SEC |
| Feb 4, 2025 | Feb 6, 2025 | EMR | Director | Awarded | 1,476 | 11,067 | SEC | ||
| Jan 27, 2025 | Jan 30, 2025 | TXN | Director | AwardedNQ Stock Option (Right to Buy) | 2,551 | 2,551 | SEC | ||
| Jan 27, 2025 | Jan 30, 2025 | TXN | Director | Awarded | 614 | 12,307 | SEC | ||
| Jan 6, 2025 | Jan 7, 2025 | GL | Director | Sold | 3,000 | $113.24 | $340k | 5,122 | SEC |
| Jan 2, 2025 | Jan 3, 2025 | GL | Director | Awarded | 1,604 | 8,122 | SEC | ||
| Jul 29, 2024 | Feb 10, 2026 | GL | Director | Gift | 2,950 | 6,518 | SEC | ||
| May 23, 2024 | May 24, 2024 | LEG | Director | Bought | 6,000 | $10.74 | $64k | 32,302 | SEC |
| Apr 25, 2024 | Apr 26, 2024 | GL | Director | Bought | 2,000 | $76.77 | $154k | 6,518 | SEC |
| Feb 26, 2024 | Feb 27, 2024 | LEG | Director | Awarded | 7,887 | $20.29 | $160k | 26,302 | SEC |
| Feb 9, 2024 | Feb 13, 2024 | EMR | Director | Sold | 2,413 | $103.18 | $249k | 9,591 | SEC |
| Feb 6, 2024 | Feb 8, 2024 | EMR | Director | Awarded | 1,867 | 12,004 | SEC | ||
| Jan 31, 2024 | Feb 2, 2024 | TXN | Director | Sold | 1,744 | $159.85 | $279k | 11,693 | SEC |
| Jan 31, 2024 | Feb 2, 2024 | TXN | Director | Exercised or settledNQ Stock Option (Right to Buy) | 978 | 0 | SEC | ||
| Jan 31, 2024 | Feb 2, 2024 | TXN | Director | Exercised options | 978 | $130.52 | $128k | 13,437 | SEC |
| Jan 25, 2024 | Jan 29, 2024 | TXN | Director | AwardedNQ Stock Option (Right to Buy) | 3,066 | 3,066 | SEC | ||
| Jan 25, 2024 | Jan 29, 2024 | TXN | Director | Awarded | 686 | 12,459 | SEC | ||
| Jan 2, 2024 | Jan 3, 2024 | GL | Director | Awarded | 1,475 | 4,518 | SEC | ||
| Mar 2, 2023 | Mar 6, 2023 | EMR | Director | Gift | 69 | 10,137 | SEC | ||
| Feb 23, 2023 | Jan 29, 2024 | TXN | Director | Gift | 1,200 | 600 | SEC | ||
| Feb 23, 2023 | Jan 29, 2024 | TXN | Director | Returned to the company | 600 | 0 | SEC | ||
| Feb 22, 2023 | Feb 23, 2023 | LEG | Director | Awarded | 4,656 | 18,415 | SEC | ||
| Feb 7, 2023 | Feb 9, 2023 | EMR | Director | Awarded | 1,933 | 10,068 | SEC | ||
| Feb 3, 2023 | Feb 7, 2023 | TXN | Director | Sold | 3,068 | $181.69 | $557k | 11,773 | SEC |
| Feb 3, 2023 | Feb 7, 2023 | TXN | Director | Exercised or settledNQ Stock Option (Right to Buy) | 2,111 | 978 | SEC | ||
| Feb 3, 2023 | Feb 7, 2023 | TXN | Director | Exercised options | 2,111 | $116.51 | $246k | 14,841 | SEC |
| Jan 26, 2023 | Jan 30, 2023 | TXN | Director | AwardedNQ Stock Option (Right to Buy) | 2,159 | 2,159 | SEC | ||
| Jan 26, 2023 | Jan 30, 2023 | TXN | Director | Awarded | 574 | 12,730 | SEC | ||
| Jan 3, 2023 | Jan 9, 2023 | GL | Director | Awarded | 1,422 | 3,043 | SEC | ||
| Jul 3, 2022 | Jul 5, 2022 | GL | Director | Withheld for tax | 395 | $100.34 | $40k | 1,621 | SEC |
| Jul 3, 2022 | Feb 10, 2026 | GL | Director | Gift | 2,844 | 3,043 | SEC |
Page 1
Sales and notices (48)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Apr 24, 2026 | Apr 27, 2026 | TXN | Director | Form 4 sale | 15,000 | $4.2M | 99.7% | Unusual | SEC |
| Apr 24, 2026 | Apr 24, 2026 | TXN | Director | Form 144 notice | 15,000 | $4.1M | Notice | SEC | |
| Feb 6, 2026 | Feb 10, 2026 | GL | Director | Form 4 sale | 1,750 | $259k | 34.2% | Unusual | SEC |
| Feb 6, 2026 | Feb 6, 2026 | GL | Director | Form 144 notice | 1,750 | $259k | Notice | SEC | |
| Feb 5, 2026 | Feb 9, 2026 | EMR | Director | Form 4 sale | 2,876 | $439k | 27.6% | Unusual | SEC |
| Feb 5, 2026 | Feb 6, 2026 | TXN | Director | Form 4 sale | 3,144 | $697k | 21.2% | Unusual | SEC |
| Feb 5, 2026 | Feb 5, 2026 | EMR | Director | Form 144 notice | 2,876 | $439k | Notice | SEC | |
| Feb 5, 2026 | Feb 5, 2026 | TXN | Director | Form 144 notice | 3,144 | $697k | Notice | SEC | |
| Jul 21, 2025 | Aug 27, 2025 | TXN | Director | Form 4 sale | 0 | $72 | 0.0% | No plan | SEC |
| Feb 19, 2025 | Feb 20, 2025 | TXN | Director | Form 4 sale | 6,186 | $1.2M | 34.6% | Unusual | SEC |
| Feb 19, 2025 | Feb 19, 2025 | TXN | Director | Form 144 notice | 6,186 | $1.2M | Notice | SEC | |
| Feb 12, 2025 | Feb 14, 2025 | EMR | Director | Form 4 sale | 20 | $3k | 0.2% | No plan | SEC |
| Feb 10, 2025 | Feb 12, 2025 | EMR | Director | Form 4 sale | 1,867 | $235k | 16.9% | No plan | SEC |
| Feb 10, 2025 | Feb 10, 2025 | EMR | Director | Form 144 notice | 1,887 | $241k | Notice | SEC | |
| Feb 4, 2025 | Feb 5, 2025 | TXN | Director | Form 4 sale | 590 | $107k | 4.8% | No plan | SEC |
| Feb 4, 2025 | Feb 4, 2025 | TXN | Director | Form 144 notice | 590 | $107k | Notice | SEC | |
| Jan 6, 2025 | Jan 7, 2025 | GL | Director | Form 4 sale | 3,000 | $340k | 36.9% | Unusual | SEC |
| Jan 6, 2025 | Jan 6, 2025 | GL | Director | Form 144 notice | 3,000 | $340k | Notice | SEC | |
| Feb 16, 2024 | Feb 16, 2024 | EMR | Director | Form 144 notice | 1,933 | $199k | Notice | SEC | |
| Feb 9, 2024 | Feb 13, 2024 | EMR | Director | Form 4 sale | 2,413 | $249k | 20.1% | No plan | SEC |
| Jan 31, 2024 | Feb 2, 2024 | TXN | Director | Form 4 sale | 1,744 | $279k | 13.0% | No plan | SEC |
| Jan 31, 2024 | Jan 31, 2024 | TXN | Director | Form 144 notice | 1,744 | $279k | Notice | SEC | |
| Feb 3, 2023 | Feb 7, 2023 | TXN | Director | Form 4 sale | 3,068 | $557k | 20.7% | Plan not stated | SEC |
| Feb 4, 2022 | Feb 8, 2022 | TXN | Director | Form 4 sale | 4,095 | $698k | 25.2% | Unusual | SEC |
| Jan 28, 2021 | Feb 1, 2021 | TXN | Director | Form 4 sale | 4,703 | $777k | 27.4% | Unusual | SEC |
| Jan 29, 2020 | Jan 31, 2020 | TXN | Director | Form 4 sale | 7,300 | $931k | 38.0% | Unusual | SEC |
| Jan 29, 2019 | Jan 31, 2019 | TXN | Director | Form 4 sale | 6,648 | $684k | 37.4% | Unusual | SEC |
| Jan 29, 2018 | Jan 29, 2018 | TXN | Director | Form 4 sale | 9,724 | $1.1M | 48.9% | Unusual | SEC |
| Oct 26, 2017 | Oct 30, 2017 | TXN | Director | Form 4 sale | 16,990 | $1.6M | 64.7% | Unusual | SEC |
| Feb 28, 2017 | Mar 2, 2017 | FLS | President & CEO | Form 4 sale | 42,500 | $2M | 31.2% | Unusual | SEC |
| Nov 2, 2016 | Nov 4, 2016 | FLS | President & CEO | Form 4 sale | 119,232 | $5M | 38.0% | Unusual | SEC |
| Aug 2, 2016 | Aug 4, 2016 | FLS | President & CEO | Form 4 sale | 84,261 | $3.8M | 21.2% | Plan not stated | SEC |
| Feb 20, 2015 | Feb 20, 2015 | FLS | President & CEO | Form 4 sale | 69,000 | $4.3M | 32.8% | Unusual | SEC |
| Feb 21, 2014 | Feb 25, 2014 | FLS | President & CEO | Form 4 sale | 87,000 | $7.1M | 39.9% | Unusual | SEC |
| Apr 29, 2013 | May 1, 2013 | FLS | President & CEO | Form 4 sale | 28,000 | $4.4M | 32.9% | Unusual | SEC |
| Nov 2, 2012 | Nov 5, 2012 | FLS | President & CEO | Form 4 sale | 25,000 | $3.4M | 26.8% | Unusual | SEC |
| Mar 2, 2011 | Mar 2, 2011 | FLS | President & CEO | Form 4 sale | 18,693 | $2.3M | 25.3% | Unusual | SEC |
| Nov 5, 2010 | Nov 8, 2010 | FLS | President & CEO | Form 4 sale | 6,813 | $699k | 10.3% | Plan not stated | SEC |
| Mar 2, 2010 | Mar 3, 2010 | FLS | President & CEO | Form 4 sale | 11,772 | $1.2M | 17.5% | Plan not stated | SEC |
| Aug 4, 2008 | Aug 4, 2008 | FLS | SVP & Chief Financial Officer | Form 4 sale | 16,803 | $2.1M | 21.9% | Unusual | SEC |
| May 1, 2008 | May 5, 2008 | FLS | SVP & Chief Financial Officer | Form 4 sale | 8,572 | $1M | 10.0% | Unusual | SEC |
| Mar 4, 2008 | Mar 4, 2008 | FLS | SVP & Chief Financial Officer | Form 4 sale | 24,287 | $2.6M | 23.2% | Unusual | SEC |
| Nov 30, 2007 | Dec 4, 2007 | FLS | SVP & Chief Financial Officer | Form 4 sale | 2,538 | $239k | 2.5% | Plan not stated | SEC |
| Nov 8, 2007 | Nov 8, 2007 | FLS | SVP & Chief Financial Officer | Form 4 sale | 3,801 | $349k | 3.9% | Plan not stated | SEC |
| Nov 2, 2007 | Nov 2, 2007 | FLS | SVP & Chief Financial Officer | Form 4 sale | 667 | $56k | 0.7% | Plan not stated | SEC |
| Aug 24, 2007 | Aug 27, 2007 | FLS | SVP & Chief Financial Officer | Form 4 sale | 2,500 | $175k | 2.6% | Plan not stated | SEC |
| Aug 20, 2007 | Aug 22, 2007 | FLS | SVP & Chief Financial Officer | Form 4 sale | 1,000 | $68k | 1.0% | Plan not stated | SEC |
| Aug 15, 2007 | Aug 16, 2007 | FLS | SVP & Chief Financial Officer | Form 4 sale | 9,000 | $631k | 8.5% | Plan not stated | SEC |